Tender Title: ECHS RE 01
Reference Number: GEM/2025/B/6121880
The tender is issued by the Department of Military Affairs, under the Ministry of Defence. This document outlines the requirements for the procurement and supply of various pharmaceutical products, notably including Tab Clopidogrel 75 mg, Oint Clotrimazole 1% (15 gm), and Mouth paint Clotrimazole 1%.
Scope of Work and Objectives
The primary objective of this tender is to solicit bids for 160,431 units of specified pharmaceutical items to ensure availability and efficacy of medical treatments within the facilities serving the military and associated healthcare services. Bidders are expected to provide high-quality pharmaceuticals that meet the strict guidelines set forth by the Ministry of Defence.
Eligibility Criteria
To qualify for participation in this tender, bidders must:
- Be a registered entity, adequately licensed to manufacture or supply pharmaceutical products.
- Meet the financial status and capability standards outlined in the tender documents.
- Comply with all applicable laws related to pharmaceutical procurement within India.
Technical Requirements
Bidders must ensure all pharmaceuticals supplied under this tender should adhere to the following technical specifications:
- Tab Clopidogrel 75 mg must comply with pharmacopoeal standards and should be manufactured as per the guidelines from the Drug Controller General of India (DCGI).
- Both Oint Clotrimazole and Mouth paint Clotrimazole must be packaged in approved and verified forms ensuring stability and shelf-life.
- Quality assurance testing reports must accompany the products delivered.
Financial Requirements
Bid submissions should detail the financial capacity of the bidder, including:
- Proposed pricing for bulk orders.
- Payment terms and conditions must align with government regulations and procurement guidelines.
Document Submission Details
All required documentation must be submitted electronically through the designated procurement platform for this tender. Document formats acceptable include PDF for technical proposals and Excel spreadsheets for financial quotations.
Special Provisions
The tender highlights provisions to encourage participation from Micro, Small, and Medium Enterprises (MSEs), as well as startups. These provisions include:
- Relaxed financial criteria for MSEs.
- Preference in evaluation processes for bids submitted by eligible MSEs and startups.
Evaluation Process
The evaluation criteria will involve:
- Technical compliance and adherence to specified quality standards.
- Pricing competitiveness.
- Past performance in supplying similar products, evaluated against a checklist to ensure compliance.
Delivery Locations
The delivery of pharmaceutical products will be made to specified military healthcare facilities as directed by the Department of Military Affairs. Bidders will be responsible for understanding the logistics arrangements necessary for timely delivery.
Contact Information
For further inquiries regarding this tender, participants are encouraged to reach out through the designated communication channels established by the Department of Military Affairs. Please ensure all questions pertain strictly to the tender requirements.
This tender is a significant opportunity for pharmaceutical suppliers to contribute to the health and operational effectiveness of our military personnel. Adhering to the outlined qualifications, technical specifications, and submission protocols is crucial for successful participation.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
5 DocumentsSimilar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, capable of providing quality pharmaceutical products. Bidders must present valid licenses for manufacturing and supply, and also demonstrate compliance with financial norms as outlined in the tender documents. Additionally, all entities must have a track record of adhering to applicable laws within the pharmaceutical sector.
All products, including Tab Clopidogrel 75 mg, Oint Clotrimazole, and Mouth paint Clotrimazole, must comply with stringent quality standards defined by the Drug Controller General of India (DCGI). Bidders must provide detailed manufacturing practices and quality assurance reports as part of their submission.
Documents must be submitted through the prescribed electronic platform in acceptable formats including PDF for technical documents and Excel for financial quotations. Ensure that all documents are clear, accessible, and adhere to the outlined submission guidelines for a valid application.
The EMD is a crucial component of the submission process, demonstrating the bidder’s commitment to fulfilling the contract terms should their bid be selected. The EMD amount, as well as specific instructions for payment, will be detailed in the tender documentation.
The evaluation process involves a rigorous assessment based on technical compliance, pricing strategies, and supplier experience. Bids will be evaluated on their alignment with the required standards and overall cost-effectiveness. Successful bidders will receive notifications about the outcome directly through the official channels as mapped out in the evaluation framework.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders